Julie Ann Goldstein - Aug 2, 2023 Form 4 Insider Report for electroCore, Inc. (ECOR)

Role: Director
Signature: /s/ Ira Kotel, attorney-in-fact
Stock symbol: ECOR
Transactions as of: Aug 2, 2023
Transactions value $: $148,936
Form type: 4
Date filed: 8/4/2023, 10:47 AM
Previous filing: May 25, 2022
Next filing: Aug 8, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ECOR	Common Stock	Award	$148K	+34K	+95.26%	$4.35	69.7K	Aug 2, 2023	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ECOR	Warrants to Purchase Common Stock	Purchase	$1.06K	+17K		$0.06^*	17K	Aug 2, 2023	Common Stock	17K	$4.35	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On August 2, 2023, pursuant to a private placement offering by the Issuer, the Reporting Person acquired 33,994 Units, each Unit consisting of (i) one share of the Issuer's Common Stock and (ii) one Warrant to purchase one-half share of the Issuer's Common Stock. The combined purchase price in the Offering was $4.4125 per Unit, inclusive of $4.35 per share of Common Stock and $0.0625 per Warrant. Each Warrant entitles the holder thereof to purchase one half of a share of Common Stock, is exercisable beginning six months from the date of issuance at an exercise price of $4.35 per share, and expires five years from the initial exercise date.
F2	Includes 4,444 shares that have vested pursuant to previously issued Deferred Stock Units; 5,556 of shares will vest monthly through March 15, 2025. All such vested and unvested shares were previously reported on Form 4 filings at the time of grant.
F3	Includes 1,665 shares held in NeuroSpine Ventures; an entity in which the Reporting Person has no voting or dispositive power over the shares. Accordingly, the Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.